IP Library Granted Patent US 8,447,393
Granted Patent B2
US 8,447,393 · App. 13/204,113 · Granted May 21, 2013

Iontophoretic electrode

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,447,393
App. No.
13/204,113
Granted
May 21, 2013
Kind
B2
Abstract

An electrode for an iontophoretic drug delivery system includes a retainer having a malleable characteristic. The retainer and a conductor are connected to a platform. The conductor and a dose controller are electrically coupled to the iontophoretic drug delivery system. A drug delivery matrix is operably connected to the platform and proximate the conductor wherein the conductor, the drug delivery matrix, and the dose controller cooperate to deliver a drug to a user when the electrode is affixed to the user and operably connected to the iontophoretic drug delivery system.

Claims (28)

1. An iontophoretic drug delivery system, comprising:

a drug delivery electrode and a return electrode;

a dose controller coupled to at least one of the drug delivery electrode and the return electrode; and

a monitor operably coupled to the dose controller for observing an electrical characteristic associated with delivery of a drug, the monitor including a sensor in communication with the monitor, wherein the sensor, monitor and dose controller cooperate to monitor at least one characteristic associated with the delivery of a drug, and automatically adjust at least one electrical characteristic of the drug delivery electrode in response to the monitored characteristic associated with the delivery of the drug.

2. The iontophoretic drug delivery system of claim 1 wherein the at least one characteristic associated with the delivery of a drug includes at least one of voltage, current and resistance.

3. The iontophoretic drug delivery system of claim 2 comprising a conductor, wherein the at least one characteristic associated with the delivery of a drug includes the amount of current associated with the conductor.

4. The iontophoretic drug delivery system of claim 3 , wherein the conductor is proximate to a treatment area.

5. The iontophoretic drug delivery system of claim 1 , wherein the electrical characteristic of the drug delivery electrode is one of voltage and current.

6. The iontophoretic drug delivery system of claim 5 , wherein the at least one electrical characteristic of the drug delivery electrode is adjusted according to a prescribed amount of medicament to be delivered.

7. The iontophoretic drug delivery system of claim 1 , wherein the dose controller, the monitor, and the current controller are located within a housing.

8. The iontophoretic drug delivery system of claim 1 , wherein the sensor includes a current shunt.

9. The iontophoretic drug delivery system of claim 1 , wherein the sensor includes a Hall Effect sensor.

10. The iontophoretic drug delivery system of claim 1 , wherein the drug delivery electrode comprises a malleable retainer.

11. A method for delivering a drug dose, the method comprising:

providing a drug delivery electrode and a return electrode;

activating the drug delivery electrode and the return electrode to deliver a drug;

sensing at least one characteristic associated with delivering the drug;

monitoring the at least one characteristic associated with delivering the drug; and

automatically adjusting at least one electrical characteristic of the drug delivery electrode in response to the monitored characteristic associated with the delivery of the drug.

12. The method of claim 11 , wherein the at least one characteristic associated with the delivery of a drug includes at least one of voltage, current and resistance.

13. The method of claim 11 , further comprising providing a conductor, wherein the at least one characteristic associated with the delivery of a drug includes the amount of current associated with the conductor.

14. The method of claim 13 , wherein the conductor is placed proximate to a treatment area.

15. The method of claim 11 , wherein the electrical characteristic of the drug delivery electrode is one of voltage and current.

16. The method of claim 15 , further comprising adjusting the at least one electrical characteristic of the drug delivery electrode according to a prescribed amount of medicament to be delivered.

17. The method of claim 11 , comprising using a dose controller to control the level of current associated with the conductor.

18. The method of claim 17 , wherein the level of current is controlled by a variable resistor.

19. The method of claim 11 , wherein a sensor is operably coupled near an area to be treated.

20. The method of claim 11 , further comprising conforming the drug delivery electrode to a contour of an area on a user to be treated.

Assignments (11)
MERGER Recorded Feb 10, 2020
From: ENCORE MEDICAL ASSET CORPORATION
To: DJO, LLC
Reel/Frame 051774/0485 →
RELEASE OF SECURITY INTEREST Recorded Mar 21, 2019
From: WELLS FARGO BANK, NATIONAL ASSOCIATION AS COLLATERAL AGENT
To: DJO, LLC; ENCORE MEDICAL, L.P.; EMPI, INC.; ENCORE MEDICAL ASSET CORPORATION; RIKCO INTERNATIONAL, LLC
Reel/Frame 048672/0661 →
RELEASE OF SECURITY INTEREST Recorded Mar 14, 2019
From: THE BANK OF NEW YORK MELLON AS SECOND LIEN AGENT
To: DJO, LLC; ENCORE MEDICAL, L.P.; EMPI, INC.; ENCORE MEDICAL ASSET CORPORATION; RIKCO INTERNATIONAL, LLC
Reel/Frame 050129/0262 →
RELEASE OF SECURITY INTEREST Recorded Mar 14, 2019
From: THE BANK OF NEW YORK MELLON AS THIRD LIEN AGENT
To: DJO, LLC; ENCORE MEDICAL, L.P.; EMPI, INC.; ENCORE MEDICAL ASSET CORPORATION; RIKCO INTERNATIONAL, LLC
Reel/Frame 048608/0932 →
RELEASE OF SECURITY INTEREST Recorded Mar 14, 2019
From: MACQUARIE US TRADING LLC AS COLLATERAL AGENT
To: DJO, LLC; ENCORE MEDICAL, L.P.; EMPI, INC.; ENCORE MEDICAL ASSET CORPORATION; RIKCO INTERNATIONAL, LLC
Reel/Frame 048655/0067 →
SECURITY AGREEMENT Recorded May 18, 2015
From: DJO, LLC; EMPI, INC.; ENCORE MEDICAL ASSET CORPORATION; ENCORE MEDICAL, L.P.; RIKCO INTERNATIONAL, LLC
To: THE BANK OF NEW YORK MELLON, AS THIRD LIEN AGENT
Reel/Frame 035707/0498 →
SECURITY AGREEMENT Recorded May 18, 2015
From: DJO, LLC; EMPI, INC.; ENCORE MEDICAL ASSET CORPORATION; ENCORE MEDICAL, L.P.; RIKCO INTERNATIONAL, LLC
To: MACQUARIE US TRADING LLC, AS COLLATERAL AGENT
Reel/Frame 035707/0398 →
SECURITY AGREEMENT Recorded May 18, 2015
From: DJO, LLC; EMPI, INC.; ENCORE MEDICAL ASSET CORPORATION; ENCORE MEDICAL, L.P.; RIKCO INTERNATIONAL, LLC
To: THE BANK OF NEW YORK MELLON, AS SECOND LIEN AGENT
Reel/Frame 035707/0454 →
RELEASE OF SECURITY INTEREST Recorded May 18, 2015
From: THE BANK OF NEW YORK MELLON, AS SECOND LIEN AGENT
To: DJO, LLC; ENCORE MEDICAL ASSET CORPORATION; RIKCO INTERNATIONAL, LLC; EMPI, INC.
Reel/Frame 035706/0457 →
SECURITY INTEREST Recorded May 7, 2015
From: DJO, LLC; EMPI, INC.; ENCORE MEDICAL ASSET CORPORATION; ENCORE MEDICAL, L.P.; RIKCO INTERNATIONAL, LLC
To: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS THE COLLATERAL AGENT
Reel/Frame 035614/0001 →
SECURITY AGREEMENT Recorded Apr 20, 2012
From: DJO, LLC; EMPI, INC.; ENCORE MEDICAL ASSET CORPORATION; RICKO INTERNATIONAL, LLC
To: THE BANK OF NEW YORK MELLON, AS SECOND LIEN AGENT
Reel/Frame 028078/0320 →